Specific antibody deficiency in children with recurrent respiratory infections: A controlled study with follow-up

Clinical and Experimental Immunology

Volumn 172, Issue 2, 2013, Pages 238-244

  Ruuskanen, O ^a   Nurkka, A ^d   Helminen, M ^c   Viljanen, M K ^b   Kayhty H ^d   Kainulainen, L ^a  

^a TURKU UNIVERSITY HOSPITAL   (Finland)

^b UNIVERSITY OF TURKU   (Finland)

^c TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^d NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

Author keywords

CVID; Immunodeficiency; Pneumococcal vaccine; Recurrent infections; Specific antibody deficiency

Indexed keywords

ANTIBODY; PNEUMOCOCCUS VACCINE;

ACUTE OTITIS MEDIA; ADOLESCENT; ANTIBODY BLOOD LEVEL; ANTIBODY RESPONSE; ARTICLE; CHILD; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME IMMUNOASSAY; FEMALE; HUMAN; HUMORAL IMMUNE DEFICIENCY; IMMUNITY; IMMUNOGLOBULIN G DEFICIENCY; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PNEUMOCOCCAL INFECTION; PNEUMONIA; PRESCHOOL CHILD; PRIORITY JOURNAL; RECURRENT INFECTION; RESPIRATORY TRACT INFECTION; REVACCINATION; SCHOOL CHILD; SEPSIS; SEROTYPE; SINUSITIS; SPECIFIC ANTIBODY DEFICIENCY; TREATMENT RESPONSE; VACCINATION;

ADOLESCENT; ANTIBODIES, BACTERIAL; BACTERIAL VACCINES; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; IMMUNOGLOBULIN G; IMMUNOLOGIC DEFICIENCY SYNDROMES; MALE; PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES; RESPIRATORY TRACT INFECTIONS; STREPTOCOCCUS PNEUMONIAE; VACCINATION; VACCINES, CONJUGATE;

EID: 84876097046     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/cei.12053     Document Type: Article

References (30)

1. Fried A, Bonilla F. Pathogenesis, diagnosis and management of primary antibody deficiencies and infections. Clin Microbiol Rev 2009; 22:396-414.
2. Notarangelo LD, Fischer A, Geha RS etal. Primary immunodeficiencies: 2009 update. J Allergy Clin Immunol 2009; 124:1161-1178.
3. Sorensen RU, Leiva LE, Javier FC III etal. Influence of age on the response to Streptococcus pneumoniae vaccine in patients with recurrent infections and normal immunoglobulin concentrations. J Allergy Clin Immunol 1998; 102:215-221.
4. Boyle RJ, Le C, Balloch A, Tang M. The clinical syndrome of antibody deficiency in children. Clin Exp Immunol 2006; 146:486-492.
5. Bossuyt X, Borgers H, Moens L, Verbinnen B, Meyts I. Age-dependent antibody response to pneumococcal polysaccharides. J Allergy Clin Immunol 2011; 127:1079-1080.
6. Koskela M, Leinonen M, Häivä VM, Timonen M, Mäkelä PH. First and second dose antibody responses to pneumococcal polysaccharide vaccine in infants. Pediatr Infect Dis 1986; 5:45-50.
7. Licciardi PV, Balloch A, Russell FM etal. Pneumococcal polysaccharide vaccine at 12 months of age produces functional immune responses. J Allergy Clin Immunol 2012; 129:794-800.
8. Sanders L, Rijkers G, Kuis W etal. Defective antipneumococcal polysaccharide antibody response in children with recurrent respiratory tract infections. J Allergy Clin Immunol 1993; 91:110-119.
9. Epstein M, Gruskay F. Selective deficiency in pneumococcal antibody response in children with recurrent infections. Ann Allergy Asthma Immunol 1995; 75:125-131.
10. Tuerlinckx D, Vermeulen F, Pékus V etal. Optimal assessment of the ability of children with recurrent respiratory tract infections to produce anti-polysaccharide antibodies. Clin Exp Immunol 2007; 149:295-302.
11. Jeurissen A, Moens L, Raes M etal. Laboratory diagnosis of specific antibody deficiency to pneumococcal capsular polysaccharide antigens. Clin Chem 2007; 53:505-510.
12. Bossuyt X, Moens L, van Hoeyveld E etal. Coexistence of (partial) immune defects and risk of recurrent respiratory infections. Clin Chem 2007; 53:124-130.
13. Borgers H, Moens L, Picard C etal. Laboratory diagnosis of specific antibody deficiency to pneumococcal capsular polysaccharide antigens by multiplex bead assay. Clin Immunol 2010; 134:198-205.
14. Salmi A, Viljanen M, Reunanen M. Intrathecal synthesis of antibodies to diphtheria and tetanus toxoids in multiple sclerosis patients. J Neuroimmunol 1981; 1:333-341.
15. Kainulainen L, Peltola V, Seppänen M etal. C4A deficiency in children and adolescents with recurrent respiratory infections. Hum Immunol 2012; 73:498-501.
16. Simell B, Lahdenkari M, Reunanen A, Käyhty H, Väkeväinen M. Effect of ageing and gender on naturally acquired antibodies to pneumococcal capsular polysaccharides and virulence-associated proteins. Clin Vaccine Immunol 2008; 15:1391-1397.
17. Hidalgo H, Moore C, Leiva LE, Sorensen RU. Preimmunization and postimmunization pneumococcal antibody titers in children with recurrent infections. Ann Allergy Asthma Immunol 1996; 76:341-346.
18. Tregoning JS, Schwartze J. Respiratory viral infections in infants: causes, clinical symptoms, virology, and immunology. Clin Microbiol Rev 2010; 23:74-98.
19. Subbarayan A, Colarusso G, Hughes SM etal. Clinical features that identify children with primary immunodeficiency diseases. Pediatrics 2011; 127:810-816.
20. Cheng YK, Decker PA, O'Byrne MM, Weiler CR. Clinical and laboratory characteristics of 75 patients with specific polysaccharide antibody deficiency syndrome. Ann Allergy Asthma Immunol 2006; 97:306-311.
21. Yong PL, Boyle J, Ballow M etal. Use of intravenous immunoglobulin and adjunctive therapies in the treatment of primary immunodeficiencies: a working group report and a study by the primary immunodeficiency committee of the American Academy of Allergy Asthma and Immunology. Clin Immunol 2010; 135:255-263.
22. Kutukculer N, Karaca NE, Demircioglu O, Aksu G. Increases in serum immunoglobulins to age-related normal levels in children with IgA and/or IgG subclass deficiency. Pediatr Allergy Immunol 2007; 18:167-173.
23. Paris K, Sorensen RU. Assessment and clinical interpretation of polysaccharide antibody responses. Ann Allergy Asthma Immunol 2007; 99:462-464.
24. O'Brien KL, Hochman M, Goldblatt D. Combined schedules of pneumococcal conjugate and polysaccharide vaccines: is hyporesponsiveness an issue? Lancet Infect Dis 2007; 7:597-606.
25. Sorensen R, Leiva L, Giangrosso P etal. Response to heptavalent conjugate Streptococcus pneumoniae vaccine in children with recurrent infections who are unresponsive to the polysaccharide vaccine. Pediatr Infect Dis J 1998; 17:685-691.
26. Ballow M. Vaccines in the assessment of patients for immune deficiency. J Allergy Clin Immunol 2012; 130:283-284.
27. Emonts M, Veenhoven R, Wiertsema S etal. Gentic polymorphism in immunoresponse genes TNFA, IL6, IL10, and TLR4 are associated with recurrent acute otitis media. Pediatrics 2007; 120:814-823.
28. Orange J, Ballow M, Stiehm ER etal. Use and interpretation of diagnostic vaccination in primary immunodeficiency: a working group report of the Basic and Clinical Immunology Interest Section of the American Academy of Allergy, Asthma & Immunology. J Allergy Clin Immunol 2012; 130:S1-24.
29. Wuorimaa T, Käyhty H, Leroy O, Eskola J. Tolerability and immunogenicity of an 11-valent pneumococcal conjugate vaccine in adults. Vaccine 2001; 19:1863-1869.
30. Modell V, Gee B, Lewis DB etal. Global study of primary immunodeficiency diseases (PI)-diagnosis, treatment, and economic impact: an updated report from the Jeffrey Modell Foundation. Immunol Res 2011; 51:61-70.